Protein supplementation after biliopancreatic diversion surgery

Protein supplementation after biliopancreatic diversion surgery - Proteinfit

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON38990

Enrollment

Registered

2013-07-22

Start date

2013-07-30

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protein deficiencies

Interventions

Providing a protein supplement.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - A BPD (DS) operation in the history. - Registered in the bariatric follow-up care of the Atrium Medical Center Parkstad.

Exclusion criteria

Exclusion criteria: - No signed informed consent form. - Inability to meet the requirements of the study to understand: Completing the questionnaires Blood draws every three months for one year

Design outcomes

Primary

Measure	Time frame
Outcomes of bloodserum: Total protein * 60.0 g/L Albumin * 35.0 g/L	—

Secondary

Measure	Time frame
Patient satisfaction and experience with the supplement.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)